Literature DB >> 18781625

Trans-ungual iontophoretic delivery of terbinafine.

Anroop B Nair1, Siva Ram K Vaka, Srinivasa M Sammeta, Hyun D Kim, Phillip M Friden, Bireswar Chakraborty, S Narasimha Murthy.   

Abstract

Successful treatment of deep-seated nail infections remains elusive as the delivery of efficacious levels of antifungal drug to the site of action is very difficult. The aim of the present study was to attain rapid trans-ungual delivery of an antifungal agent, terbinafine, via the topical route using iontophoresis. Initial studies revealed that application of current (0.5 mA/cm(2)) could significantly enhance the trans-ungual delivery of terbinafine. An increase in the applied current or duration of current application enhanced the trans-ungual delivery of terbinafine. Permeation of terbinafine through the nail and drug load in the nail correlated well with the applied electrical dose. Release of drug from nails loaded using iontophoresis followed a two-phase release profile. Light microscopy studies substantiated the capability of iontophoresis to drive a charged molecule across the nail plate. The results of these studies indicate that iontophoresis could be developed as a potential technique for onychomycosis therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18781625     DOI: 10.1002/jps.21555

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

Review 1.  Transungual permeation: current insights.

Authors:  Ronak S Bhuptani; Ketaki M Deshpande; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

2.  An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.

Authors:  Anroop B Nair; Hyun D Kim; Shawn P Davis; Robert Etheredge; Michael Barsness; Phillip M Friden; S Narasimha Murthy
Journal:  Pharm Res       Date:  2009-07-07       Impact factor: 4.200

3.  Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy.

Authors:  Julie Dutet; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2012-08-07       Impact factor: 4.200

4.  Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Dharmik M Mehta; Pragna K Shelat
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

Review 5.  Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.

Authors:  Sudhir Baswan; Gerald B Kasting; S Kevin Li; Randy Wickett; Brian Adams; Sean Eurich; Ryan Schamper
Journal:  Mycoses       Date:  2017-01-18       Impact factor: 4.377

6.  Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Mukesh C Gohel; Pragna K Shelat
Journal:  AAPS PharmSciTech       Date:  2011-12-22       Impact factor: 3.246

7.  Trans-ungual delivery of itraconazole hydrochloride by iontophoresis.

Authors:  Avadhesh Kushwaha; Melissa Jacob; H N Shiva Kumar; Shobharani Hiremath; Sacchidanand Aradhya; Michael A Repka; S Narasimha Murthy
Journal:  Drug Dev Ind Pharm       Date:  2014-12-08       Impact factor: 3.225

8.  Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.

Authors:  Boaz Amichai; Rachel Mosckovitz; Henri Trau; Orit Sholto; Shirly Ben-Yaakov; Michael Royz; David Barak; Boaz Nitzan; Avner Shemer
Journal:  Mycopathologia       Date:  2009-12-13       Impact factor: 2.574

9.  Influence of pH on transungual passive and iontophoretic transport.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

10.  Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.